BBNX
Beta Bionics, Inc.
19.40$
-5.4%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +170.0% | +54.9% | +16.3% | +11.0% | +22.4% | -13.7% | +31.7% | +17.3% | +17.9% | -14.0% | +15.9% | – | |
| – | +76.0% | +74.3% | +21.5% | +11.9% | +12.3% | -0.9% | +23.8% | +13.0% | +8.6% | -15.1% | +17.2% | – | |
| – | +313.2% | +42.3% | +12.3% | +10.3% | +31.1% | -23.3% | +39.4% | +20.9% | +25.3% | -13.2% | +15.0% | – | |
| – | +15.7% | +22.8% | +15.9% | -19.0% | +79.2% | -17.6% | +16.9% | -7.6% | +23.6% | +2.2% | -1.1% | – | |
| – | +18.6% | +4.8% | +29.4% | +12.3% | -7.8% | +40.6% | +19.0% | +0.5% | +8.6% | +11.8% | -0.2% | – | |
| – | +34.2% | +24.0% | +19.3% | +0.1% | +24.3% | +11.7% | +17.2% | -0.7% | +9.0% | +16.1% | +9.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.